Physician profile
Jonathan Michael Roth
NPI 1831271410
$45,672.78
in general payments reported to CMS, 2019-2025
13 companies · $32K in 2025
The $32K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,449 · 2020: $495 · 2021: $940 · 2022: $4,818 · 2023: $3,190 · 2024: $3,167 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $2,243 · Travel and Lodging: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,310.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,605.00 |
| Food and Beverage | $2,243.19 |
| Travel and Lodging | $1,813.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $39,160.51 | 2022-2025 | Arthrex |
| Seapearl East, INC | $4,971.97 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $333.73 | 2019-2025 | Euflexxa |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Smith+Nephew, INC. | $263.79 | 2019-2025 | Ultrabutton, Q-Fix, Acufex |
| Depuy Synthes Sales INC. | $218.12 | 2019-2025 | Orthovisc, Monovisc |
| Bioventus LLC | $171.59 | 2019-2025 | Durolane, Durolane, Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $99.27 | 2020 | |
| Pacira Therapeutics, INC. | $54.93 | 2019 | |
| Vericel Corporation | $35.82 | 2019-2022 | |
| Stryker Corporation | $32.66 | 2024 | Variax |
| Acera Surgical, INC. | $28.90 | 2025 | Restrata Wound Matrix |
| Sanofi-Aventis U.S. LLC | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.